Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
about
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityHeat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II TrialAdoptive cell therapy for sarcomaImmunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme BTargeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody.Lysosomal rerouting of Hsp70 trafficking as a potential immune activating tool for targeting melanoma.Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT CellsViral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk.Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation.The complex function of hsp70 in metastatic cancer.Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2.Immunohistochemical and Flow Cytometric Analysis of Intracellular and Membrane-Bound Hsp70, as a Putative Biomarker of Glioblastoma Multiforme, Using the cmHsp70.1 Monoclonal Antibody.
P2860
Q26773135-AD67B532-E9EE-4A61-8B00-0F6131B9C991Q26858884-8B2277D1-B642-4784-8713-F47B5AC2DE40Q27009541-9D635669-C6F8-45E6-B1A1-9862865599F0Q28729023-3D2040EC-44F1-4C6B-A1A0-F11198ECDF2DQ30497901-9CF93DD3-FA9C-424C-9E3B-291981D9643EQ30530764-7D295DA8-6855-4EB5-BC25-9F3F918D594FQ35959395-0829F721-120E-4AE9-B10F-9FAADC2AED71Q36373365-4101A6CC-1152-43E8-B0E7-8CBE377A7111Q36964967-97F6DE50-8664-4C4C-A721-E6AE7A277A24Q38173257-53BAF2FC-DF8E-47CA-BE41-F0329800D8E1Q41611120-7F9B99BC-9C8B-4C21-9DBC-AAD6F44BDBD3Q47117842-B43F770B-84D0-42BC-A0D2-ECEF3696E969Q47362523-DCA8878C-AB44-44CE-9103-52017F52D2EA
P2860
Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Anti-tumor activity of patient ...... immunotherapy--a case report.
@en
Anti-tumor activity of patient ...... immunotherapy--a case report.
@nl
type
label
Anti-tumor activity of patient ...... immunotherapy--a case report.
@en
Anti-tumor activity of patient ...... immunotherapy--a case report.
@nl
prefLabel
Anti-tumor activity of patient ...... immunotherapy--a case report.
@en
Anti-tumor activity of patient ...... immunotherapy--a case report.
@nl
P2093
P2860
P356
P1476
Anti-tumor activity of patient ...... immunotherapy--a case report.
@en
P2093
Beate Wagner
Doris Mayr
Gabriele Multhoff
Kathrin Hube
Mathias Gehrmann
Michael Molls
Rolf Issels
Stefan Stangl
Valeria Milani
Wolfgang Hiddemann
P2860
P2888
P356
10.1186/1479-5876-7-50
P577
2009-06-23T00:00:00Z
P5875
P6179
1002571771